v3.26.1
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Stockholders’ Equity [Abstract]  
Schedule of Stock Option Activity

The following table summarizes stock option activity during the six months ended June 30, 2026:

 

(in thousands, except share and per share amounts)   Number of
Shares		     Weighted-
average
Exercise
Price		     Weighted-
average
Remaining
Contractual
Term
(years)		     Aggregate
Intrinsic
Value		  
Outstanding at January 1, 2026     9,759,882     $ 2.63       6.83     $ 545  
Options granted     -     $ -       -       -  
Options exercised     (23,959 )   $ 1.48       -       -  
Options cancelled     (76,041 )   $ 1.49       -       -  
Outstanding at June 30, 2026     9,659,882     $ 2.64       6.32     $ 1,104  
Exercisable at June 30, 2026     5,681,578     $ 3.18       4.44     $ 560  
Schedule of Stock-Based Compensation Expense

The following summarizes the components of stock-based compensation expense in the consolidated statements of operations for the six months ended June 30, 2026 and 2025 respectively:

 

(in thousands)   Three Months
Ended
June 30,
2026		     Three Months
Ended
June 30,
2025		     Six Months
Ended
June 30,
2026		     Six Months
Ended
June 30,
2025		  
Research and development   $ 319     $ 627     $ 667     $ 1,457  
General and administrative     1,039       907       2,188       2,153  
Total   $ 1,358     $ 1,534     $ 2,855     $ 3,610